Rite Aid (RAD) Feb. Front-End Comps Flat; Total Drugstore Sales Fell 3.7
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Rite-Aid (RAD) Feb Sales Fall Victim to Choppy Trends, Shift in Flu Season
March 7, 2013 1:22 PM ESTGoldman Sachs today maintained a Neutral rating on Rite-Aid (NYSE: RAD) and raised its price target to $1.85 (from $1.70). This morning Rite-Aid reported light February sales, with noticeable little benefit from the intense flu season. Analysts believe that, while flu incidence remain elevated, the virus... More
